Novartis had sought to overturn a clause in Indian Patents Law that restricts patent protection for newer forms of existing molecules. The case started in 1997 when Novartis filed a plea for a patent for Glivec.
Following is the timeline of the patent case in India.
1997: Novartis files a patent application in India for its drug Gilvec
2005: India introduces the Indian Patent Act preventing frivolous patents.
Jan 2006: The Patent Controller in Chennai denies Novartis a patent
May 2006: Novartis challenges the Indian government and four other companies in the Madras High Court
Aug 2007: The Madras High Court rules against Novartis’ case
June 2009: The Intellectual Property Appellate Board rejects a fresh appeal
August 2009: Novartis approaches the Supreme Court of India
April 1, 2013: Supreme Court rejects Novartis’ plea for patent